ResMed Chairman & CEO Michael Farrell Receives 13,547 Performance Shares
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ResMed Inc. (NYSE: RMD) Form 4 Filing Update
Insider: Michael J. Farrell (Chairman and CEO) Transaction Date: August 14, 2026 Filing Date: October 1, 2026 Transaction: Award / Grant (Code A) Shares Acquired: 13,547 @ $0.00 Shares Owned Following Transaction: 479,803 (Direct) Indirect Holdings: 2,090 shares via Family Trust
Note: Represents earned performance-based restricted stock units granted in November 2025 following performance metric certification by the compensation committee.
Comprehensive Analysis
Transaction Overview
On October 1, 2026, ResMed Inc. ($RMD) filed a Form 4 detailing an equity award to Chairman and Chief Executive Officer Michael J. Farrell. On August 14, 2026, Farrell was credited with 13,547 shares of ResMed Common Stock at $0.00 per share.
Award Details
According to the footnote disclosure, these shares correspond to performance-based restricted stock units originally granted on November 20, 2025. The shares were earned on August 14, 2026, upon the compensation committee's certification that pre-established performance metrics were satisfied. The units vest in one-third increments each year on the anniversary of the grant.
Post-Transaction Holdings
- Direct Ownership: 479,803 shares
- Indirect Ownership: 2,090 shares held indirectly through the Lisette and Michael Farrell Family Trust
Market Significance
This transaction reflects routine executive equity compensation and performance certification rather than discretionary open-market buying or selling. As an award (Transaction Code: A) delivered at zero cost, it does not provide an incremental market pricing signal and is categorized as having Low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.